Gene Symbol | REL |
---|---|
Entrez Gene | 5966 |
Alt Symbol | C-Rel |
Species | Human |
Gene Type | protein-coding |
Description | v-rel avian reticuloendotheliosis viral oncogene homolog |
Other Description | oncogene REL, avian reticuloendotheliosis|proto-oncogene c-Rel |
Swissprots | Q17RU2 Q04864 Q6LDY0 Q2PNZ7 |
Accessions | AAA52073 ABC40747 CBX47437 EAX00028 Q04864 AA279919 AK123369 AK303926 BAG64854 BC051005 BC117191 AAI17192 BC143885 AAI43886 BG036646 BX111941 CN414487 HY123671 X75042 CAA52954 XM_011533010 XP_011531312 NM_001291746 NP_001278675 NM_002908 NP_002899 |
Function | Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF- kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an in |
Subcellular Location | Nucleus {ECO:0000250}. |
Top Pathways | Viral carcinogenesis, Transcriptional misregulation in cancer |
c-Rel peptide - ab7557 from Abcam
|
||||||||||
REL / C-Rel Antibody Blocking Peptide - LS-E10815 from LifeSpan Bioscience
|
||||||||||
REL / C-Rel Antibody Blocking Peptide - LS-E8211 from LifeSpan Bioscience
|
||||||||||
REL / C-Rel Antibody Blocking Peptide - LS-E27305 from LifeSpan Bioscience
|
||||||||||
REL / C-Rel Antibody Blocking Peptide - LS-E13254 from LifeSpan Bioscience
|
||||||||||
REL / C-Rel Antibody Blocking Peptide - LS-E13719 from LifeSpan Bioscience
|
||||||||||
c-Rel Blocking Peptide - NB600-474PEP from Novus Biologicals
|
||||||||||
c-Rel Peptide - P2000 from Novus Biologicals
|
||||||||||
C-rel-NFkB-Antibody-C-term-Blocking-Peptide - BP6336c from Abgent, a WuXi AppTec company
|
||||||||||
c-Rel blocking peptide - GTX88187-PEP from GeneTex
|
||||||||||
c-Rel peptide - GTX27557 from GeneTex
|
||||||||||
Human REL protein - orb245687 from Biorbyt
|
||||||||||
REL Immunizing peptide - orb17800 from Biorbyt
|
||||||||||
c-Rel Blocking Peptide - abx063189 from Abbexa
|
||||||||||
c-Rel Peptide - AC21-2127-P from Abcore
|
||||||||||
REL control peptide - R1010CP from Acris Antibodies
|
||||||||||
REL Peptide - 42-533P from ProSci
|
||||||||||
Recombinant V-Rel Reticuloendotheliosis Viral Oncogene Homolog (REL) - RPP741Mu01 from Uscn Life Science Inc.
|
||||||||||
c-Rel Blocking Peptide - CBP1995 from Cohesion Biosciences
|
||||||||||
c-Rel (N497) Peptide - BS1314P from Bioworld Technology
|
||||||||||
p-c-Rel (S503) Peptide - BS4839P from Bioworld Technology
|
||||||||||
Recombinant human Proto-oncogene c-Rel protein - CSB-EP178194h CSB-BP178194h CSB-MP178194h from Cusabio
|
||||||||||
Recombinant Human Proto-oncogene c-Rel(REL),partial - CSB-RP178194h from Cusabio
|
||||||||||
c-Rel (1-300) - sc-4030 from Santa Cruz Biotechnology
|
||||||||||
Proto-oncogene c-Rel protein - RPC141089 from Biomatik
|